Cargando…

Improved hippocampal dose with reduced margin radiotherapy for glioblastoma multiforme

BACKGROUND: To dosimetrically evaluate the effect of reduced margin radiotherapy on hippocampal dose for glioblastoma multiforme (GBM) patients. METHODS: GBM patients enrolled on the Radiation Therapy Oncology Group (RTOG) 0825 trial at our institution were identified. Standard RTOG 0825 expansions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Arif N, Ogunleye, Tomi, Hardy, Claire W, Shu, Hui-Kuo, Curran, Walter J, Crocker, Ian R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904484/ https://www.ncbi.nlm.nih.gov/pubmed/24411020 http://dx.doi.org/10.1186/1748-717X-9-20

Ejemplares similares

Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy
por: Nguyen, Dan, et al.
Publicado: (2014)

Six degrees of freedom CBCT‐based positioning for intracranial targets treated with frameless stereotactic radiosurgery
por: Dhabaan, Anees, et al.
Publicado: (2012)

Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
por: Glynn, Aisling M., et al.
Publicado: (2019)

INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study
por: Giordano, Frank A, et al.
Publicado: (2014)

Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
por: Gebhardt, Brian J, et al.
Publicado: (2014)

Effectiveness of 6D couch with daily cone beam computed tomography in reducing PTV margins for glioblastoma multiforme
por: Pruthi, Deep Shankar, et al.
Publicado: (2023)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Positive correlation between blood glucose and radiotherapy doses to the central gustatory system in Glioblastoma Multiforme patients
por: Duma, Marciana N., et al.
Publicado: (2019)

Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
por: Choi, Jinyeong, et al.
Publicado: (2020)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Dose-escalated intensity-modulated radiotherapy and irradiation of subventricular zones in relation to tumor control outcomes of patients with glioblastoma multiforme
por: Kusumawidjaja, Grace, et al.
Publicado: (2016)

Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
por: Eaton, Bree R, et al.
Publicado: (2013)

A potential role of PI3K inhibition in radiotherapy of glioblastoma multiforme
por: Langhans, Julia, et al.
Publicado: (2015)

Prospective study evaluating the radiosensitizing effect of reduced doses of temozolomide in the treatment of Egyptian patients with glioblastoma multiforme
por: Gaber, May, et al.
Publicado: (2013)

A Rare Case of Concurrent Herpes Simplex Encephalitis and Glioblastoma Multiforme
por: Sayal, Parag, et al.
Publicado: (2018)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
por: Chou, Shang-Yu, et al.
Publicado: (2018)

Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme
por: Greer, Liana, et al.
Publicado: (2017)

Effects of Reduced Graphene Oxides on Apoptosis and Cell Cycle of Glioblastoma Multiforme
por: Szczepaniak, Jaroslaw, et al.
Publicado: (2018)

Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model
por: Goodarzi, Arash, et al.
Publicado: (2020)

Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme
por: Chatzikonstantinou, Georgios, et al.
Publicado: (2019)

Erythema multiforme provoked by radiotherapy
por: Machoń, Natalia Joanna, et al.
Publicado: (2023)

Critical Parameters Determining Standard Radiotherapy Treatment Outcome for Glioblastoma Multiforme: A Computer Simulation
por: Dionysiou, D.D, et al.
Publicado: (2008)

Hypofractionated short‐course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database
por: Mak, Kimberley S., et al.
Publicado: (2017)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

Targeting Metabolic Remodeling in Glioblastoma Multiforme
por: Wolf, Amparo, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gr7uhop29vbfnbsi1t4ascf815